• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续皮下胰岛素输注的定性证据综合:可接受性、实施、公平性。

A Qualitative Evidence Synthesis of Continuous Subcutaneous Insulin Infusion: Acceptability, Implementation, Equity.

机构信息

Canary Islands Health Research Institute Foundation, Fundacion Canaria Instituto de Investigacion Sanitaria de Canarias, Santa Cruz de Tenerife, Spain.

Network for Research on Chronicity, Primary Care, and Health Promotion, Red de Investigacion en Cronicidad Atencion Primaria y Prevencion y Promocion de la Salud, Barcelona, Spain.

出版信息

Nurs Health Sci. 2024 Dec;26(4):e13177. doi: 10.1111/nhs.13177.

DOI:10.1111/nhs.13177
PMID:39428561
Abstract

This work provides a synthesis of the perceptions of people with type 1 diabetes mellitus (T1DM) and healthcare professionals about the acceptability, implementation, and equity of continuous subcutaneous insulin infusion (CSII). A qualitative evidence synthesis was carried out. Three online databases (Medline, Embase, and Web of Science) were searched. Qualitative articles which were available in Spanish or English were included. A descriptive thematic synthesis was conducted according to PRISMA and ENTREQ guidelines. Thirty-two references met the inclusion criteria of the study and were included out of an initial 345 identified references. Seven main themes were identified: (a) acceptability, (b) adaptation to the insulin pump, (c) facilitators for the adequate use of insulin pump, (d) variability of acceptability, (e) barriers for the use of insulin pump, (f) feasibility and implementation considerations, and (g) equity. CSII is well accepted by most people with T1DM, with some exceptions. CSII can relieve management burden, increase autonomy and flexibility and improve family relationships. There were multiple perceived barriers to its continued use. Future studies should continue to analyze inequalities in access and use of the CSII.

摘要

本研究综合了 1 型糖尿病患者(T1DM)和医疗保健专业人员对连续皮下胰岛素输注(CSII)的可接受性、实施和公平性的看法。进行了定性证据综合。在三个在线数据库(Medline、Embase 和 Web of Science)中进行了检索。纳入了可提供西班牙语或英语版本的定性文章。根据 PRISMA 和 ENTREQ 指南进行了描述性主题综合。从最初确定的 345 篇参考文献中,有 32 篇参考文献符合研究的纳入标准。确定了七个主要主题:(a)可接受性,(b)对胰岛素泵的适应,(c)促进胰岛素泵的合理使用,(d)可接受性的可变性,(e)使用胰岛素泵的障碍,(f)可行性和实施注意事项,(g)公平性。CSII 被大多数 T1DM 患者所接受,但也有一些例外。CSII 可以减轻管理负担,提高自主性和灵活性,并改善家庭关系。但也存在一些持续使用的感知障碍。未来的研究应继续分析 CSII 获得和使用方面的不平等问题。

相似文献

1
A Qualitative Evidence Synthesis of Continuous Subcutaneous Insulin Infusion: Acceptability, Implementation, Equity.连续皮下胰岛素输注的定性证据综合:可接受性、实施、公平性。
Nurs Health Sci. 2024 Dec;26(4):e13177. doi: 10.1111/nhs.13177.
2
Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study.成人 1 型糖尿病患者获得胰岛素泵治疗的障碍和促进因素:一项定性研究。
Acta Diabetol. 2021 Jan;58(1):93-105. doi: 10.1007/s00592-020-01595-5. Epub 2020 Aug 30.
3
Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.成人 1 型糖尿病患者持续皮下胰岛素输注:来自公共卫生系统的结果。
Diabetes Technol Ther. 2019 Aug;21(8):440-447. doi: 10.1089/dia.2019.0097. Epub 2019 Jun 13.
4
Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study.成人使用持续皮下胰岛素输注的体验:一项定性研究。
Med Princ Pract. 2020;29(3):255-261. doi: 10.1159/000503705. Epub 2019 Sep 27.
5
An integrative review of the psychosocial facilitators and challenges of continuous subcutaneous insulin infusion therapy in type 1 diabetes.1 型糖尿病患者采用持续皮下胰岛素输注治疗的心理社会促进因素和挑战的综合回顾。
J Adv Nurs. 2018 Mar;74(3):528-538. doi: 10.1111/jan.13463. Epub 2017 Oct 19.
6
Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.持续皮下胰岛素输注治疗:胰岛素泵入门知识。
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):e1-13; quiz e14-7. doi: 10.1331/JAphA.2009.08122.
7
Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.30年后的持续皮下胰岛素输注(CSII):仍是胰岛素治疗的最佳选择。
Diabetes Metab Res Rev. 2009 Feb;25(2):99-111. doi: 10.1002/dmrr.931.
8
Young people with type 1 diabetes mellitus: Attitudes, perceptions, and experiences of diabetes management and continuous subcutaneous insulin infusion therapy.1型糖尿病青少年:糖尿病管理及持续皮下胰岛素输注治疗的态度、认知与体验
J Eval Clin Pract. 2017 Jun;23(3):554-561. doi: 10.1111/jep.12670. Epub 2017 Jan 4.
9
Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.动态血糖监测在接受持续皮下胰岛素输注治疗的1型糖尿病患者中的临床价值
Endocrinol Diabetes Nutr (Engl Ed). 2018 Dec;65(10):556-563. doi: 10.1016/j.endinu.2018.04.003. Epub 2018 Jun 12.
10
Effectiveness and equity of continuous subcutaneous insulin infusions in pediatric type 1 diabetes: A systematic review and meta-analysis of the literature.连续皮下胰岛素输注在儿科 1 型糖尿病中的疗效和公平性:文献的系统评价和荟萃分析。
Diabetes Res Clin Pract. 2021 Feb;172:108643. doi: 10.1016/j.diabres.2020.108643. Epub 2020 Dec 31.